Cooperation of protease-activated receptor 1 and integrin αvβ5in thrombin-mediated lung cancer cell invasion

Oncology Reports

Volumn 28, Issue 2, 2012, Pages 553-560

  Zhu, Lingyun ^a   Wang, Xiudong ^a   Wu, Jie ^a   Mao, Dekui ^a   Xu, Zhishan ^a   He, Ziyang ^a   Yu, Aiping ^a  

^a BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

Integrin; Protease activated receptor 1; Thrombin; Tumor invasion

Indexed keywords

ALPHAVBETA5 INTEGRIN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN;

ARTICLE; CANCER INVASION; CANCER RISK; CELL ADHESION; CELL MIGRATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RAT; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION;

ADENOCARCINOMA; ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; IMMOBILIZED PROTEINS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RATS; RATS, WISTAR; RECEPTOR, PAR-1; RECEPTORS, VITRONECTIN; SIGNAL TRANSDUCTION; THROMBIN;

EID: 84863434929     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1851     Document Type: Article

References (39)

1. Rickels FR, Levine M and Edwards RL: Hemostatic alterations in cancer patients. Cancer Metastasis Rev 11: 237-248, 1992.
2. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM and Melton LJ III: Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 160: 809-815, 2000. (Pubitemid 30165241)
3. Kasthuri R, Taubman M and Mackman N: Role of tissue factor in cancer. J Clin Oncol 27: 4834-4838, 2009.
4. Amirkhosravi A, Meyer T, Amaya M, Davila M, Mousa SA, Robson T and Francis JL: The role of tissue factor pathway inhibitor in tumor growth and metastasis. Semin Thromb Hemost 33: 643-652, 2007. (Pubitemid 350157007)
5. Liu Y, Jiang P, Capkova K, Xue D, Ye L, Sinha SC, Mackman N, Janda KD and Liu C: Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res 71: 6492-6502, 2011.
6. Hron G, Kollars M, Binder BR, Eichinger S and Kyrle PA: Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 296: 397-402, 2006. (Pubitemid 44127523)
7. Zigler M, Kamiya T, Brantley EC, Villares GJ and Bar-Eli M: PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis. Cancer Res 71: 6561-6566, 2011.
8. Wojtukiewicz MZ, Zacharski LR, Memoli VA, Kisiel W, Kudryk BJ, Rousseau SM and Stump DC: Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ. Am J Clin Pathol 93: 516-521, 1990. (Pubitemid 20128848)
9. Zacharski LR, Memoli VA, Morain WD, Schlaeppi JM and Rousseau SM: Cellular localization of enzymatically active thrombin in intact human tissues by hirudin binding. Thromb Haemost 73: 793-797, 1995.
10. Ornstein DL and Zacharski LR: Treatment of cancer with anticoagulants: rationale in the treatment of melanoma. Int J Hematol 73: 157-161, 2001. (Pubitemid 33758855)
11. Even-Ram S, Uziely B, Cohen P, Grisaru-Granovsky S, Maoz M, Ginzburg Y, Reich R, Vlodavsky I and Bar-Shavit R: Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med 4: 909-914, 1998. (Pubitemid 28364029)
12. Grisaru-Granovsky S, Salah Z, Maoz M, Pruss D, Beller U and Bar-Shavit R: Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples. Int J Cancer 113: 372-378, 2005. (Pubitemid 40038703)
13. Henrikson KP, Salazar SL, Fenton JW II and Pentecost BT: Role of thrombin receptor in breast cancer invasiveness. Br J Cancer 79: 401-406, 1999.
14. Radjabi AR, Sawada K, Jagadeeswaran S, Eichbichler A, Kenny HA, Montag A, Bruno K and Lengyel E: Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and beta1-integrin on the cell surface. J Biol Chem 283: 2822-2834, 2008.
15. Yang RS, Chiang HS, Tang CH, Yeh CS and Huang TF: Rhodostomin inhibits thrombin-enhanced adhesion of ROS 17/2.8 cells through the blockade of alphavbeta3 integrin. Toxicon 46: 387-393, 2005. (Pubitemid 41218733)
16. Even-Ram SC, Maoz M, Pokroy E, Reich R, Katz BZ, Gutweini P, Altevogti P and Bar-Shavit R: Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha v beta 5 integrin. J Biol Chem 276: 10952-10962, 2001. (Pubitemid 38089274)
17. Chiang HS, Yang RS and Huang TF: Thrombin enhances the adhesion and migration of human colon adenocarcinoma cells via increased beta 3-integrin expression on the tumor cell surface and their inhibition by the snake venom peptide, rhodostomin. Br J Cancer 73: 902-908, 1996.
18. Chiang HS, Yang RS and Huang TF: The Arg-Gly-Aspcontaining peptide, rhodostomin, inhibits in vitro cell adhesion to extracellular matrices and platelet aggregation caused by Saos-2 human osteosarcoma cells. Br J Cancer 71: 265-270, 1995.
19. Bode W, Turk D and Karshikov A: The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships. Protein Sci 1: 426-471, 1992. (Pubitemid 23016868)
20. Bar-Shavit R, Sabbah V, Lampugnani MG, Marchisio PC, Fenton JW II, Vlodavsky I and Dejana E: An Arg-Gly-Asp sequence within thrombin promotes endothelial cell adhesion. J Cell Biol 112: 335-344, 1991. (Pubitemid 21909623)
21. Bar-Shavit R, Eskohjido Y, Fenton JW II, Esko JD and Vlodavsky I: Thrombin adhesive properties: induction by plasmin and heparan sulfate. J Cell Biol 123: 1279-1287, 1993. (Pubitemid 23352435)
22. Tsopanoglou NE, Andriopoulou P and Maragoudakis ME: On the mechanism of thrombin-induced angiogenesis: involvement of alphavbeta3-integrin. Am J Physiol Cell Physiol 283: C1501-C1510, 2002. (Pubitemid 35178442)
23. Tsopanoglou NE, Papaconstantinou ME, Flordellis CS and Maragoudakis ME: On the mode of action of thrombin-induced angiogenesis: thrombin peptide, TP508, mediates effects in endothelial cells via alphavbeta3 integrin. Thromb Haemost 92: 846-857, 2004. (Pubitemid 39402919)
24. Sajid M, Zhao R, Pathak A, Smyth SS and Stouffer GA: Alphavbeta3-integrin antagonists inhibit thrombin-induced proliferation and focal adhesion formation in smooth muscle cells. Am J Physiol Cell Physiol 285: C1330-C1338, 2003. (Pubitemid 37296310)
25. Papaconstantinou ME, Carrell CJ, Pineda AO, Bobofchak KM, Mathews FS, Flordellis CS, Maragoudakis ME, Tsopanoglou NE and Di Cera E: Thrombin functions through its RGD sequence in a non-canonical conformation. J Biol Chem 280: 29393-29396, 2005. (Pubitemid 41177010)
26. Bar-Shavit R, Eldor A and Vlodavsky I: Binding of thrombin to subendothelial extracellular matrix. Protection and expression of functional properties. J Clin Invest 84: 1096-1104, 1989. (Pubitemid 19247578)
27. Hernández-Rodríguez NA, Correa E, Sotelo R, Gómez-Ruiz C, Contreras-Paredes A, Green L: Thrombin is present in the lungs of patients with primary extremity osteosarcoma and pulmonary metastases. Int J Biol Markers 17: 189-195, 2002. (Pubitemid 35370062)
28. Fenton JW II: Regulation of thrombin generation and functions. Semin Thromb Hemost 14: 234-240, 1988.
29. Weitz JI, Hudoba M, Massel D, Maraganore J and Hirsh J: Clot-bound thrombin is protected from inhibition by heparinantithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. J Clin Invest 86: 385-391, 1990. (Pubitemid 20271869)
30. Begonja AJ, Geiger J, Rukoyatkina N, Rauchfuss S, Gambaryan S and Walter U: Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxaneA2 and inhibited by cGMP/cGMP-dependent protein kinase. Blood 109: 616-618, 2007. (Pubitemid 46105961)
31. Malaver E, Romaniuk MA, D'atri LP, Pozner RG, Negrotto S, Benzadón R, and Schattner M: NF-kappaB inhibitors impair platelet activation responses. J Thromb Haemost 7: 1333-1343, 2009.
32. Shankar H, Garcia A, Prabhakar J, Kim S and Kunapull SP: P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. J Thromb Haemost 4: 638-647, 2006.
33. Liu J, Schuff-Werner P and Steiner M: Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells. Biochem Biophys Res Commun 343: 183-189, 2006.
34. Chang LH, Chen CH, Huang DY, Pai HC, Pan SL and Teng CM: Thrombin induces expression of twist and cell motility via the hypoxia-inducible factor-1á translational pathway in colorectal cancer cells. J Cell Physiol 226: 1060-1068, 2011.
35. Sil H, Sen T and Chatterjee A: Fibronectin-integrin (alpha5beta1) modulates migration and invasion of murine melanoma cell line B16F10 by involving MMP-9. Oncol Res 19: 335-348, 2011.
36. Hu CT, Wu JR, Cheng CC, Wang S, Wang HT, Lee MC, Wang LJ, Pan SM, Chang TY and Wu WS: Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2. Clin Exp Metastasis 28: 851-863, 2011.
37. Sood AK, Fletcher MS, Coffin JE, Yang M, Seftor EA, Gruman LM, Gershenson DM and Hendrix MJC: Functional role of matrix metalloproteinases in tumor cell plasticity. Am J Obstet Gynecol 190: 899-909, 2004. (Pubitemid 38561505)
38. Sharma N, Seftor RE, Seftor EA, Gruman LM, Heidger PM Jr, Cohen MB, Lubaroff DM and Hendrix MJ: Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: role in vasculogenic mimicry. Prostate 50: 189-201, 2002. (Pubitemid 34137446)
39. Leger AJ, Jacques SL, Badar J, Kaneider NC, Derian CK, Andrade-Gordon P, Covic L and Kuliopulos A: Blocking the protease-activated receptor 1-4 heterodimer in platelet-mediated thrombosis. Circulation 113: 1244-1254, 2006.